U.S. market Closed. Opens in 5 hours 34 minutes

ADMA | ADMA Biologics, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for ADMA we got that it has average fundamentals where Valuation is considered to be overvalued, Profitability is moderate, Growth is good and Health is strong.

Valuation (33%)

Company Industry
P/E Ratio (TTM) 109.77 -22.01
PEG Ratio (TTM) 0.11 15.69
P/S Ratio (TTM) 11.60 48.43
P/B Ratio (TTM) 20.28 18.71
P/FCF Ratio (TTM) 57.92 -2.79
Price to 5YR AVG Earnings Ratio -25.45 -3.21
Price to 5YR AVG FCF Ratio -49.07 -8.75

Profitability (55%)

Company Industry
ROA (TTM) 9.24% -5.02%
ROE (TTM) 22.14% 16.95%
Net Profit Margin (TTM) 10.53% -1,552.13%
ROIC 5YR AVG -21.41% 14.51%

Growth (63%)

4QTR AVG 3YR AVG 5YR AVG
EPS -91.42% 23.55% 33.98%
Revenue 15.86% 69.45% 73.26%
Net Income -91.66% -12.25% 5.85%
Cash Flow 597.50% -21.87% 19.25%

Health (63%)

Company Industry
Current Ratio (TTM) 6.87 6.08
Quick Ratio (TTM) 2.80 5.80
D/E Ratio (TTM) 0.70 -15.32
Interest Coverage (TTM) 4.16 -1.96
Piotroski F-Score 5 5
Altman Z-Score 12.80 13.86
LTL to 5YR AVG FCF -1.67 0.16
Shares Outstanding Growth 5YR AVG 39.15% 128.58%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙